|
WO2009030254A1
(en)
*
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
|
PL2591114T3
(pl)
|
2010-07-06 |
2017-08-31 |
Glaxosmithkline Biologicals Sa |
Immunizacja dużych ssaków małymi dawkami rna
|
|
AU2011276234B2
(en)
|
2010-07-06 |
2016-02-25 |
Glaxosmithkline Biologicals S.A. |
Liposomes with lipids having an advantageous pKa- value for RNA delivery
|
|
PT3243526T
(pt)
|
2010-07-06 |
2020-03-04 |
Glaxosmithkline Biologicals Sa |
Distribuição de arn para despoletar múltiplas vias imunitárias
|
|
PT3981427T
(pt)
|
2010-08-31 |
2022-06-27 |
Glaxosmithkline Biologicals Sa |
Lipossomas peguilados para entrega de arn codificador de imunogénio
|
|
TR201903651T4
(tr)
|
2010-10-11 |
2019-04-22 |
Glaxosmithkline Biologicals Sa |
Antijen uygulama platformları.
|
|
EP2729165B1
(en)
|
2011-07-06 |
2017-11-08 |
GlaxoSmithKline Biologicals SA |
Immunogenic combination compositions and uses thereof
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
WO2015051214A1
(en)
|
2013-10-03 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
DK3134131T3
(en)
|
2014-04-23 |
2022-02-07 |
Modernatx Inc |
Nucleic acid vaccines
|
|
PT3766916T
(pt)
|
2014-06-25 |
2022-11-28 |
Acuitas Therapeutics Inc |
Novos lípidos e formulações de nanopartículas lipídicas para distribuição de ácidos nucleicos
|
|
EP3180349B1
(en)
|
2014-08-12 |
2025-03-12 |
Monash University |
Lymph directing prodrugs and therapeutic uses thereof
|
|
EP3283059B1
(en)
|
2015-04-13 |
2024-01-03 |
CureVac Manufacturing GmbH |
Method for producing rna compositions
|
|
US20180303925A1
(en)
|
2015-04-27 |
2018-10-25 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-Modified RNA For Inducing an Adaptive Immune Response
|
|
AU2016285852B2
(en)
|
2015-06-29 |
2020-12-17 |
Acuitas Therapeutics Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
WO2017015463A2
(en)
|
2015-07-21 |
2017-01-26 |
Modernatx, Inc. |
Infectious disease vaccines
|
|
US12150980B2
(en)
|
2015-07-30 |
2024-11-26 |
Modernatx, Inc. |
Concatemeric peptide epitope RNAs
|
|
US11564893B2
(en)
|
2015-08-17 |
2023-01-31 |
Modernatx, Inc. |
Methods for preparing particles and related compositions
|
|
CN108137482B
(zh)
|
2015-09-08 |
2024-03-15 |
莫纳什大学 |
定向淋巴的前药
|
|
WO2017049245A2
(en)
*
|
2015-09-17 |
2017-03-23 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
MA46080A
(fr)
|
2015-10-22 |
2019-07-10 |
Modernatx Inc |
Vaccins à base d'acide nucléique contre le virus varicelle-zona (vzv)
|
|
EP3364950A4
(en)
|
2015-10-22 |
2019-10-23 |
ModernaTX, Inc. |
VACCINES AGAINST TROPICAL DISEASES
|
|
MA45209A
(fr)
|
2015-10-22 |
2019-04-17 |
Modernatx Inc |
Vaccins contre les maladies sexuellement transmissibles
|
|
MA46255A
(fr)
*
|
2015-10-22 |
2019-07-31 |
Modernatx Inc |
Vaccins anticancéreux
|
|
EP3718565B1
(en)
|
2015-10-22 |
2022-04-27 |
ModernaTX, Inc. |
Respiratory virus vaccines
|
|
CA3002922A1
(en)
*
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
|
LT3368507T
(lt)
*
|
2015-10-28 |
2023-03-10 |
Acuitas Therapeutics Inc. |
Nauji lipidai ir lipidų nanodalelių kompozicijos, skirtos nukleorūgščių tiekimui
|
|
JP7080172B2
(ja)
|
2015-12-10 |
2022-06-03 |
モデルナティエックス インコーポレイテッド |
治療薬の送達のための組成物及び方法
|
|
WO2017106799A1
(en)
|
2015-12-17 |
2017-06-22 |
Modernatx, Inc. |
POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASE
|
|
ES2913626T5
(en)
|
2015-12-22 |
2025-05-12 |
Modernatx Inc |
Compounds and compositions for intracellular delivery of agents
|
|
US10465190B1
(en)
|
2015-12-23 |
2019-11-05 |
Modernatx, Inc. |
In vitro transcription methods and constructs
|
|
WO2017201340A2
(en)
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding relaxin
|
|
CA3024507A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding .alpha.-galactosidase a for the treatment of fabry disease
|
|
US20190298657A1
(en)
*
|
2016-05-18 |
2019-10-03 |
Modernatx, Inc. |
Polynucleotides Encoding Acyl-CoA Dehydrogenase, Very Long-Chain for the Treatment of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
|
|
EP3458105B1
(en)
|
2016-05-18 |
2024-01-17 |
Modernatx, Inc. |
Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1
|
|
JP7246930B2
(ja)
*
|
2016-05-18 |
2023-03-28 |
モデルナティエックス インコーポレイテッド |
インターロイキン－１２（ｉｌ１２）をコードするポリヌクレオチドおよびその使用
|
|
MA45050A
(fr)
*
|
2016-05-18 |
2019-03-27 |
Modernatx Inc |
Polynucléotides codant pour la lipoprotéine lipase destinés au traitement de l'hyperlipidémie
|
|
WO2017201349A1
(en)
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding citrin for the treatment of citrullinemia type 2
|
|
WO2017201347A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
US12128113B2
(en)
|
2016-05-18 |
2024-10-29 |
Modernatx, Inc. |
Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
|
|
US20200085916A1
(en)
|
2016-05-18 |
2020-03-19 |
Modernatx, Inc. |
Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria
|
|
MA45172B1
(fr)
|
2016-06-07 |
2021-11-30 |
Modernatx Inc |
Arn modifié codant pour des polypeptides vegf-a, formulations et utilisations associées
|
|
ES2928475T3
(es)
|
2016-09-14 |
2022-11-18 |
Modernatx Inc |
Composiciones de ARN de alta pureza y métodos para su preparación
|
|
WO2018075980A1
(en)
|
2016-10-21 |
2018-04-26 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
|
US12491261B2
(en)
|
2016-10-26 |
2025-12-09 |
Acuitas Therapeutics, Inc. |
Lipid nanoparticle formulations
|
|
US20200163878A1
(en)
*
|
2016-10-26 |
2020-05-28 |
Curevac Ag |
Lipid nanoparticle mrna vaccines
|
|
EP3538067A1
(en)
|
2016-11-08 |
2019-09-18 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
EP3538146A4
(en)
|
2016-11-11 |
2020-07-15 |
ModernaTX, Inc. |
INFLUENZA VACCINE
|
|
MA50335A
(fr)
*
|
2016-12-08 |
2020-08-19 |
Modernatx Inc |
Vaccins à acide nucléique contre des virus respiratoires
|
|
US11384352B2
(en)
|
2016-12-13 |
2022-07-12 |
Modernatx, Inc. |
RNA affinity purification
|
|
EP3558354A1
(en)
|
2016-12-23 |
2019-10-30 |
CureVac AG |
Lassa virus vaccine
|
|
MX2019008303A
(es)
|
2017-01-11 |
2019-12-02 |
Univ Pennsylvania |
Ácido ribonucleico modificado con nucleósidos para inducir una respuesta inmune contra el virus zika.
|
|
EA201991804A1
(ru)
*
|
2017-02-01 |
2020-02-07 |
МОДЕРНАТиЭкс, ИНК. |
ИММУНОМОДУЛИРУЮЩИЕ ТЕРАПЕВТИЧЕСКИЕ КОМПОЗИЦИИ мРНК, КОДИРУЮЩЕЙ ПЕПТИДЫ С АКТИВИРУЮЩЕЙ ОНКОГЕННОЙ МУТАЦИЕЙ
|
|
EP3582790A4
(en)
|
2017-02-16 |
2020-11-25 |
ModernaTX, Inc. |
VERY POWERFUL IMMUNOGENIC COMPOSITIONS
|
|
WO2018170336A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
|
US11576961B2
(en)
|
2017-03-15 |
2023-02-14 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
WO2018170260A1
(en)
*
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Respiratory syncytial virus vaccine
|
|
WO2018170270A1
(en)
*
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Varicella zoster virus (vzv) vaccine
|
|
US11752206B2
(en)
*
|
2017-03-15 |
2023-09-12 |
Modernatx, Inc. |
Herpes simplex virus vaccine
|
|
JP7220154B2
(ja)
|
2017-03-15 |
2023-02-09 |
モデルナティエックス インコーポレイテッド |
アミノ脂質の結晶形態
|
|
EP3596041B1
(en)
*
|
2017-03-15 |
2022-11-02 |
ModernaTX, Inc. |
Compound and compositions for intracellular delivery of therapeutic agents
|
|
US20200030432A1
(en)
|
2017-03-17 |
2020-01-30 |
Modernatx, Inc. |
Zoonotic disease rna vaccines
|
|
US11905525B2
(en)
|
2017-04-05 |
2024-02-20 |
Modernatx, Inc. |
Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins
|
|
US11357856B2
(en)
|
2017-04-13 |
2022-06-14 |
Acuitas Therapeutics, Inc. |
Lipids for delivery of active agents
|
|
US20200054737A1
(en)
*
|
2017-04-26 |
2020-02-20 |
Modema TX, Inc. |
Herpes simplex virus vaccine
|
|
WO2018200892A1
(en)
|
2017-04-27 |
2018-11-01 |
The Trustees Of The University Of Pennsylvania |
NUCLEOSIDE-MODIFIED mRNA-LIPID NANOPARTICLE LINEAGE VACCINE FOR HEPATITIS C VIRUS
|
|
CA3061612A1
(en)
*
|
2017-04-28 |
2018-11-01 |
Acuitas Therapeutics, Inc. |
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
CA3063531A1
(en)
|
2017-05-16 |
2018-11-22 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
|
|
AU2018270111B2
(en)
|
2017-05-18 |
2022-07-14 |
Modernatx, Inc. |
Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof
|
|
WO2018225871A1
(ja)
*
|
2017-06-09 |
2018-12-13 |
協和発酵キリン株式会社 |
カチオン性脂質としての化合物
|
|
WO2018232006A1
(en)
*
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Polynucleotides encoding coagulation factor viii
|
|
US12077501B2
(en)
|
2017-06-14 |
2024-09-03 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
EP3638215A4
(en)
|
2017-06-15 |
2021-03-24 |
Modernatx, Inc. |
RNA FORMULATIONS
|
|
US10780183B2
(en)
|
2017-06-19 |
2020-09-22 |
Translate Bio, Inc. |
Messenger RNA therapy for the treatment of Friedreich's ataxia
|
|
CN111107843B
(zh)
|
2017-06-30 |
2024-01-09 |
财团法人工业技术研究院 |
化合物用于制备治疗自体免疫神经疾病及/或神经退化性疾病的药物的用途以及其液体剂型与控释剂型的药物制剂
|
|
US11633365B2
(en)
*
|
2017-08-04 |
2023-04-25 |
Kyowa Kirin Co., Ltd. |
Nucleic acid-containing lipid nanoparticle
|
|
CA3073020A1
(en)
|
2017-08-16 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
WO2019036030A1
(en)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
|
|
CA3073018A1
(en)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
US11542225B2
(en)
|
2017-08-17 |
2023-01-03 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
US11912982B2
(en)
|
2017-08-18 |
2024-02-27 |
Modernatx, Inc. |
Methods for HPLC analysis
|
|
MA49913A
(fr)
|
2017-08-18 |
2021-05-05 |
Modernatx Inc |
Variants d'arn polymérase
|
|
EP3668522B1
(en)
|
2017-08-18 |
2024-09-11 |
ModernaTX, Inc. |
Efficacious mrna vaccines
|
|
EP3668977A4
(en)
|
2017-08-18 |
2021-04-21 |
Modernatx, Inc. |
HPLC ANALYTICAL PROCESSES
|
|
US11883497B2
(en)
|
2017-08-29 |
2024-01-30 |
Puretech Lyt, Inc. |
Lymphatic system-directing lipid prodrugs
|
|
EP4306524A3
(en)
|
2017-08-29 |
2024-09-11 |
PureTech LYT, Inc. |
Lymphatic system-directing lipid prodrugs
|
|
JP7275111B2
(ja)
|
2017-08-31 |
2023-05-17 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子の生成方法
|
|
MA50253A
(fr)
|
2017-09-14 |
2020-07-22 |
Modernatx Inc |
Vaccins à arn contre le virus zika
|
|
MA50522B1
(fr)
*
|
2017-10-31 |
2022-09-30 |
Astrazeneca Ab 151 85 Soedertaelje |
Nanoparticules lipidiques pour l'administration d'un arn modifié codant pour un polypeptide vegf-a
|
|
MA50801A
(fr)
*
|
2017-11-22 |
2020-09-30 |
Modernatx Inc |
Polynucléotides codant pour la phénylalanine hydroxylase pour le traitement de la phénylcétonurie
|
|
MA50803A
(fr)
|
2017-11-22 |
2020-09-30 |
Modernatx Inc |
Polynucléotides codant pour l'ornithine transcarbamylase pour le traitement de troubles du cycle de l'urée
|
|
WO2019104195A1
(en)
*
|
2017-11-22 |
2019-05-31 |
Modernatx, Inc. |
Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemia
|
|
AU2018392716B2
(en)
|
2017-12-20 |
2025-03-13 |
Translate Bio, Inc. |
Improved composition and methods for treatment of ornithine transcarbamylase deficiency
|
|
EP3735270A1
(en)
|
2018-01-05 |
2020-11-11 |
Modernatx, Inc. |
Polynucleotides encoding anti-chikungunya virus antibodies
|
|
EP3746090A4
(en)
|
2018-01-29 |
2021-11-17 |
ModernaTX, Inc. |
RSV RNA Vaccines
|
|
AU2019212237B2
(en)
|
2018-01-29 |
2024-12-12 |
Merck Sharp & Dohme Llc |
Stabilized RSV F proteins and uses thereof
|
|
AU2019216307A1
(en)
*
|
2018-01-30 |
2020-07-09 |
Modernatx, Inc. |
Compositions and methods for delivery of agents to immune cells
|
|
US12064513B2
(en)
|
2018-03-27 |
2024-08-20 |
Nof Corporation |
Cationic lipid exhibiting improved intracellular dynamics
|
|
WO2019204451A1
(en)
*
|
2018-04-17 |
2019-10-24 |
Carnegie Mellon University |
Enhanced lipid nanoparticle drug delivery using a negatively charged polymer
|
|
AU2019271132A1
(en)
|
2018-05-15 |
2020-11-12 |
Translate Bio, Inc. |
Subcutaneous delivery of messenger RNA
|
|
EP3796893A1
(en)
*
|
2018-05-23 |
2021-03-31 |
Modernatx, Inc. |
Delivery of dna
|
|
CN112437767B
(zh)
|
2018-05-24 |
2023-10-27 |
川斯勒佰尔公司 |
硫酯阳离子脂质
|
|
CA3100214A1
(en)
|
2018-05-30 |
2019-12-05 |
Translate Bio, Inc. |
Cationic lipids comprising a steroidal moiety
|
|
AU2019277355A1
(en)
|
2018-05-30 |
2020-12-17 |
Translate Bio, Inc. |
Phosphoester cationic lipids
|
|
JP7441802B2
(ja)
|
2018-05-30 |
2024-03-01 |
トランスレイト バイオ， インコーポレイテッド |
ビタミンカチオン性脂質
|
|
CN112384205B
(zh)
|
2018-05-30 |
2024-05-03 |
川斯勒佰尔公司 |
信使rna疫苗及其用途
|
|
KR20210018323A
(ko)
|
2018-06-06 |
2021-02-17 |
매사추세츠 인스티튜트 오브 테크놀로지 |
진핵 세포에서의 번역을 위한 원형 rna
|
|
EP3826608A1
(en)
|
2018-07-23 |
2021-06-02 |
Translate Bio, Inc. |
Dry power formulations for messenger rna
|
|
KR20210091120A
(ko)
|
2018-08-29 |
2021-07-21 |
트랜슬레이트 바이오 인코포레이티드 |
Mrna-로딩된 지질 나노입자를 제조하는 개선된 공정
|
|
EP3846776A1
(en)
*
|
2018-09-02 |
2021-07-14 |
ModernaTX, Inc. |
Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiency
|
|
MA53615A
(fr)
*
|
2018-09-14 |
2021-07-21 |
Modernatx Inc |
Polynucléotides codant pour le polypeptide a1, de la famille de l'uridine diphosphate glycosyltransférase 1, pour le traitement du syndrome de crigler-najjar
|
|
US20230145188A1
(en)
|
2018-09-14 |
2023-05-11 |
Translate Bio, Inc. |
Composition and methods for treatment of methylmalonic acidemia
|
|
US12383508B2
(en)
|
2018-09-19 |
2025-08-12 |
Modernatx, Inc. |
High-purity peg lipids and uses thereof
|
|
JP7526168B2
(ja)
|
2018-09-19 |
2024-07-31 |
モデルナティエックス インコーポレイテッド |
Ｐｅｇ脂質及びそれらの使用
|
|
EP3853202A1
(en)
*
|
2018-09-19 |
2021-07-28 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
US12090235B2
(en)
*
|
2018-09-20 |
2024-09-17 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
IL322436A
(en)
|
2018-09-21 |
2025-09-01 |
Acuitas Therapeutics Inc |
Systems and methods for producing lipid nanoparticles and liposomes
|
|
CN118307422A
(zh)
*
|
2018-10-01 |
2024-07-09 |
阿尔尼拉姆医药品有限公司 |
用于递送活性剂的可生物降解脂质
|
|
BR112021006270A2
(pt)
|
2018-10-02 |
2021-07-06 |
Intellia Therapeutics Inc |
lipídeos de amina ionizáveis
|
|
EA202190688A1
(ru)
|
2018-10-09 |
2021-06-07 |
Дзе Юниверсити Оф Бритиш Коламбиа |
Композиции и системы, содержащие трансфекционно-компетентные везикулы, не содержащие органических растворителей и детергентов, и связанные с ними способы
|
|
CA3112837A1
(en)
|
2018-10-19 |
2020-04-23 |
Translate Bio, Inc. |
Pumpless encapsulation of messenger rna
|
|
JP7483294B2
(ja)
|
2018-11-09 |
2024-05-15 |
トランスレイト バイオ， インコーポレイテッド |
層間エステル、チオエステル、ジスルフィドおよび無水部分を含む２，５－ジオキソピペラジン脂質
|
|
US20220016265A1
(en)
|
2018-11-09 |
2022-01-20 |
Translate Bio, Inc. |
Messenger rna therapy for treatment of ocular diseases
|
|
EP3876994A2
(en)
|
2018-11-09 |
2021-09-15 |
Translate Bio, Inc. |
Peg lipidoid compounds
|
|
CA3117866A1
(en)
|
2018-11-09 |
2020-05-14 |
Translate Bio, Inc. |
Multi-peg lipid compounds
|
|
AU2019378763B2
(en)
|
2018-11-12 |
2025-06-26 |
Translate Bio, Inc. |
Methods for inducing immune tolerance
|
|
CN109320479B
(zh)
*
|
2018-11-13 |
2021-03-16 |
上海克琴科技有限公司 |
一种抗坏血酸四异棕榈酸酯的简便合成方法
|
|
WO2020106903A1
(en)
|
2018-11-21 |
2020-05-28 |
Translate Bio, Inc. |
Cationic lipid compounds and compositions thereof for use in the delivery of messenger rna
|
|
BR112021010853A2
(pt)
|
2018-12-05 |
2021-08-31 |
Intellia Therapeutics, Inc. |
Lipídios de amina modificados
|
|
US20220087935A1
(en)
|
2019-01-07 |
2022-03-24 |
Translate Bio, Inc. |
Composition and Methods for Treatment of Primary Ciliary Dyskinesia
|
|
WO2020146805A1
(en)
|
2019-01-11 |
2020-07-16 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
|
KR20210133218A
(ko)
|
2019-01-31 |
2021-11-05 |
모더나티엑스, 인크. |
볼텍스 믹서 및 연계된 방법, 시스템 및 이의 장치
|
|
CA3128215A1
(en)
|
2019-01-31 |
2020-08-06 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
|
US11351242B1
(en)
|
2019-02-12 |
2022-06-07 |
Modernatx, Inc. |
HMPV/hPIV3 mRNA vaccine composition
|
|
US11851694B1
(en)
|
2019-02-20 |
2023-12-26 |
Modernatx, Inc. |
High fidelity in vitro transcription
|
|
MA55037A
(fr)
|
2019-02-20 |
2021-12-29 |
Modernatx Inc |
Variants d'arn polymérase pour le coiffage co-transcriptionnel
|
|
MA55082A
(fr)
*
|
2019-03-01 |
2022-01-05 |
Flagship Pioneering Innovations Vi Llc |
Compositions, procédés, et kits pour l'administration de polyribonucléotides
|
|
CN113874502A
(zh)
|
2019-03-11 |
2021-12-31 |
摩登纳特斯有限公司 |
补料分批体外转录方法
|
|
MA55321A
(fr)
|
2019-03-15 |
2022-01-19 |
Modernatx Inc |
Vaccins à base d'arn contre le vih
|
|
EP3956303A1
(en)
|
2019-04-18 |
2022-02-23 |
Translate Bio, Inc. |
Cystine cationic lipids
|
|
ES2972014T3
(es)
|
2019-04-22 |
2024-06-10 |
Translate Bio Inc |
Lípidos catiónicos de tioéster
|
|
US20220402862A1
(en)
*
|
2019-04-25 |
2022-12-22 |
Intellia Therapeutics, Inc. |
Ionizable amine lipids and lipid nanoparticles
|
|
US12453759B2
(en)
|
2019-05-03 |
2025-10-28 |
Translate Bio, Inc. |
Di-thioester cationic lipids
|
|
JP2022532075A
(ja)
|
2019-05-08 |
2022-07-13 |
アストラゼネカ アクチボラグ |
Ｖｅｇｆ－ａポリペプチドをコードする改変ｒｎａを送達するために脂質ナノ粒子を使用する方法、及びこの脂質ナノ粒子を含む医薬組成物
|
|
WO2020237227A1
(en)
|
2019-05-22 |
2020-11-26 |
Massachusetts Institute Of Technology |
Circular rna compositions and methods
|
|
WO2020243540A1
(en)
|
2019-05-31 |
2020-12-03 |
Translate Bio, Inc. |
Macrocyclic lipids
|
|
CN117945938A
(zh)
|
2019-06-21 |
2024-04-30 |
川斯勒佰尔公司 |
三(羟甲基)甲基甘氨酸和柠檬酸脂质
|
|
WO2020257611A1
(en)
|
2019-06-21 |
2020-12-24 |
Translate Bio, Inc. |
Cationic lipids comprising an hydroxy moiety
|
|
KR20220078557A
(ko)
|
2019-07-08 |
2022-06-10 |
트랜슬레이트 바이오 인코포레이티드 |
개선된 mrna 로딩된 지질 나노입자 및 이의 제조 방법
|
|
MX2022000934A
(es)
|
2019-07-23 |
2022-02-14 |
Translate Bio Inc |
Composiciones estables de nanoparticulas lipidicas cargadas de arnm y procesos de fabricacion.
|
|
WO2021026358A1
(en)
*
|
2019-08-07 |
2021-02-11 |
Moderna TX, Inc. |
Compositions and methods for enhanced delivery of agents
|
|
US20230172858A1
(en)
|
2019-08-30 |
2023-06-08 |
Glaxosmithkline Biologicals Sa |
Jet mixing lipid nanoparticle manufacturing process
|
|
AU2020350759A1
(en)
|
2019-09-19 |
2022-03-31 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
BR112022004771A2
(pt)
*
|
2019-09-19 |
2022-06-21 |
Modernatx Inc |
Compostos e composições de lipídio de grupo de cabeça para entrega intracelular de agentes terapêuticos
|
|
BR112022004936A2
(pt)
*
|
2019-09-19 |
2022-06-14 |
Modernatx Inc |
Compostos lipídicos contendo carbonato e composições para distribuição intracelular de agentes terapêuticos
|
|
AU2020348376A1
(en)
|
2019-09-20 |
2022-04-07 |
Translate Bio, Inc. |
mRNA encoding engineered CFTR
|
|
WO2021081058A1
(en)
|
2019-10-21 |
2021-04-29 |
Translate Bio, Inc. |
Compositions, methods and uses of messenger rna
|
|
US12378560B2
(en)
|
2019-10-29 |
2025-08-05 |
Northwestern University |
Sequence multiplicity within spherical nucleic acids
|
|
US20240122854A1
(en)
*
|
2019-11-27 |
2024-04-18 |
Acuitas Therapeutics, Inc. |
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
WO2021113777A2
(en)
|
2019-12-04 |
2021-06-10 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
CA3162368A1
(en)
|
2019-12-20 |
2021-06-24 |
Shrirang KARVE |
Rectal delivery of messenger rna
|
|
AU2020405214A1
(en)
|
2019-12-20 |
2022-08-11 |
Translate Bio, Inc. |
Improved process of preparing mRNA-loaded lipid nanoparticles
|
|
US12435035B2
(en)
|
2020-01-09 |
2025-10-07 |
Guide Therapeutics, Llc |
Nanomaterials
|
|
WO2021142245A1
(en)
|
2020-01-10 |
2021-07-15 |
Translate Bio, Inc. |
Compounds, pharmaceutical compositions and methods for modulating expression of muc5b in lung cells and tissues
|
|
TW202139976A
(zh)
|
2020-01-31 |
2021-11-01 |
美商現代公司 |
製備脂質奈米顆粒之方法
|
|
US12194089B2
(en)
|
2020-02-04 |
2025-01-14 |
CureVac SE |
Coronavirus vaccine
|
|
US11241493B2
(en)
|
2020-02-04 |
2022-02-08 |
Curevac Ag |
Coronavirus vaccine
|
|
JP7438604B2
(ja)
*
|
2020-02-07 |
2024-02-27 |
モデルナティエックス インコーポレイテッド |
ＳＡＲＳ－ＣＯＶ－２ ｍＲＮＡドメインワクチン
|
|
WO2021168284A1
(en)
*
|
2020-02-21 |
2021-08-26 |
GIE Medical, Inc. |
Polymer-encapsulated drug particles
|
|
EP4110296A1
(en)
|
2020-02-25 |
2023-01-04 |
Translate Bio, Inc. |
Improved processes of preparing mrna-loaded lipid nanoparticles
|
|
JP2023518295A
(ja)
|
2020-03-20 |
2023-04-28 |
オルナ セラピューティクス インコーポレイテッド |
環状ｒｎａ組成物及び方法
|
|
US20230134550A1
(en)
|
2020-03-24 |
2023-05-04 |
Generation Bio Co. |
Non-viral dna vectors and uses thereof for expressing gaucher therapeutics
|
|
CN115667530A
(zh)
|
2020-03-24 |
2023-01-31 |
世代生物公司 |
非病毒dna载体和其用于表达因子ix治疗剂的用途
|
|
CN111349014A
(zh)
*
|
2020-03-30 |
2020-06-30 |
绵阳达高特新材料有限公司 |
一种方酸甲胺甲酯的制备方法
|
|
EP4077272B1
(en)
*
|
2020-04-09 |
2024-09-18 |
Suzhou Abogen Biosciences Co., Ltd. |
Lipid nanoparticle composition
|
|
US12194157B2
(en)
|
2020-04-09 |
2025-01-14 |
Finncure Oy |
Carrier for targeted delivery to a host
|
|
WO2021205077A1
(en)
|
2020-04-09 |
2021-10-14 |
Finncure Oy |
Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
|
|
WO2021204179A1
(en)
|
2020-04-09 |
2021-10-14 |
Suzhou Abogen Biosciences Co., Ltd. |
Nucleic acid vaccines for coronavirus
|
|
CN118490818A
(zh)
|
2020-04-22 |
2024-08-16 |
生物技术欧洲股份公司 |
冠状病毒疫苗
|
|
EP4146680A1
(en)
|
2020-05-07 |
2023-03-15 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
|
EP4146265A1
(en)
|
2020-05-07 |
2023-03-15 |
Translate Bio, Inc. |
Optimized nucleotide sequences encoding sars-cov-2 antigens
|
|
US20230181619A1
(en)
|
2020-05-07 |
2023-06-15 |
Translate Bio, Inc. |
Improved compositions for cftr mrna therapy
|
|
AU2021269137A1
(en)
*
|
2020-05-08 |
2022-12-15 |
Orna Therapeutics, Inc. |
Circular RNA compositions and methods
|
|
US20230226219A1
(en)
|
2020-05-14 |
2023-07-20 |
Translate Bio, Inc. |
Peg lipidoid compounds
|
|
JP2023526284A
(ja)
|
2020-05-15 |
2023-06-21 |
トランスレイト バイオ， インコーポレイテッド |
ｍＲＮＡ送達のための脂質ナノ粒子製剤
|
|
US20240042015A1
(en)
|
2020-05-19 |
2024-02-08 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
CA3179444A1
(en)
|
2020-05-20 |
2021-11-25 |
Avak Kahvejian |
Immunogenic compositions and uses thereof
|
|
AU2021275223A1
(en)
|
2020-05-20 |
2023-02-02 |
Flagship Pioneering Innovations Vi, Llc. |
Coronavirus antigen compositions and their uses
|
|
WO2021243301A2
(en)
|
2020-05-29 |
2021-12-02 |
Flagship Pioneering Innovations Vi, Llc. |
Trem compositions and methods relating thereto
|
|
KR20230029685A
(ko)
|
2020-05-29 |
2023-03-03 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
Trem 조성물 및 이에 관련된 방법
|
|
CN114206463B
(zh)
*
|
2020-06-30 |
2024-06-11 |
苏州艾博生物科技有限公司 |
脂质化合物和脂质纳米颗粒组合物
|
|
WO2022006527A1
(en)
|
2020-07-02 |
2022-01-06 |
Maritime Therapeutics, Inc. |
Compositions and methods for reverse gene therapy
|
|
BR112023000327A2
(pt)
|
2020-07-16 |
2023-01-31 |
Acuitas Therapeutics Inc |
Lipídeos catiônicos para o uso em nanopartículas lipídicas
|
|
CN116437964A
(zh)
*
|
2020-07-17 |
2023-07-14 |
世代生物公司 |
用于将多核苷酸封装成减小尺寸的脂质纳米颗粒以及其新型调配物的方法
|
|
BR112023001648A2
(pt)
|
2020-07-27 |
2023-04-04 |
Anjarium Biosciences Ag |
Moléculas de dna de fita dupla, veículo de entrega e método para preparar uma molécula de dna com extremidade em grampo
|
|
CA3190790A1
(en)
|
2020-08-06 |
2022-02-10 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
|
AU2021329900A1
(en)
*
|
2020-08-18 |
2023-03-16 |
Ohio State Innovation Foundation |
Bioinspired lipid derivatives and uses thereof
|
|
US11406703B2
(en)
|
2020-08-25 |
2022-08-09 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
|
US12419948B2
(en)
|
2020-08-31 |
2025-09-23 |
The Broad Institute, Inc. |
Immunogenic compositions and use thereof
|
|
AU2021336976A1
(en)
|
2020-09-03 |
2023-03-23 |
Flagship Pioneering Innovations Vi, Llc |
Immunogenic compositions and uses thereof
|
|
WO2022060871A1
(en)
|
2020-09-15 |
2022-03-24 |
Verve Therapeutics, Inc. |
Lipid formulations for gene editing
|
|
CA3194863A1
(en)
|
2020-10-06 |
2022-04-14 |
Shrirang KARVE |
Improved process and formulation of lipid nanoparticles
|
|
CA3198411A1
(en)
|
2020-10-12 |
2022-04-21 |
Translate Bio, Inc. |
Improved process of preparing mrna-loaded lipid nanoparticles
|
|
US20220133631A1
(en)
|
2020-10-12 |
2022-05-05 |
Translate Bio, Inc. |
Process of preparing ice-based lipid nanoparticles
|
|
BR112023006710A2
(pt)
|
2020-10-14 |
2023-10-03 |
George Mason Res Foundation Inc |
Métodos de fabricação de nanopartícula lipídica e composições derivadas da mesma
|
|
WO2022099194A1
(en)
|
2020-11-09 |
2022-05-12 |
Translate Bio, Inc. |
Improved compositions for delivery of codon-optimized mrna
|
|
IL303165A
(en)
|
2020-11-25 |
2023-07-01 |
Translate Bio Inc |
Stable liquid lipid nanoparticle formulations
|
|
WO2022112855A1
(en)
|
2020-11-27 |
2022-06-02 |
Guangzhou Ribobio Co., Ltd |
Lipid compound and the composition thereof
|
|
AU2021245162B2
(en)
*
|
2020-11-27 |
2023-12-07 |
Guangzhou Ribobio Co., Ltd |
Lipid compound and the composition thereof
|
|
CN113185421B
(zh)
*
|
2020-11-27 |
2022-01-25 |
广州市锐博生物科技有限公司 |
脂质化合物及其组合物
|
|
US20230242474A1
(en)
*
|
2020-11-27 |
2023-08-03 |
Guangzhou Ribobio Co., Ltd |
Lipid compound and the composition thereof
|
|
WO2022110099A1
(en)
|
2020-11-30 |
2022-06-02 |
Guangzhou Argorna Biopharmaceuticals Co., Ltd. |
Coronavirus vaccines and uses thereof
|
|
WO2022140252A1
(en)
|
2020-12-21 |
2022-06-30 |
Beam Therapeutics Inc. |
Nanomaterials comprising ester-linked acetals
|
|
KR20230164648A
(ko)
|
2020-12-22 |
2023-12-04 |
큐어백 에스이 |
SARS-CoV-2 변이체에 대한 RNA 백신
|
|
KR20230135585A
(ko)
|
2020-12-23 |
2023-09-25 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
변형된 trem의 조성물 및 이의 용도
|
|
US12329811B2
(en)
|
2021-01-11 |
2025-06-17 |
Modernatx, Inc. |
Seasonal RNA influenza virus vaccines
|
|
EP4277929A1
(en)
|
2021-01-14 |
2023-11-22 |
Translate Bio, Inc. |
Methods and compositions for delivering mrna coded antibodies
|
|
KR20230121616A
(ko)
*
|
2021-01-14 |
2023-08-18 |
쑤저우 아보젠 바이오사이언시스 컴퍼니 리미티드 |
지질 화합물 및 지질 나노입자 조성물
|
|
AU2022210313A1
(en)
|
2021-01-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Nanomaterials
|
|
EP4281080A4
(en)
|
2021-01-20 |
2025-09-24 |
Beam Therapeutics Inc |
NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
|
|
MX2023007788A
(es)
|
2021-01-24 |
2023-11-17 |
Michael David Forrest |
Inhibidores de la atp sintasa, usos cosmeticos y terapeuticos.
|
|
AU2021425941A1
(en)
|
2021-02-08 |
2023-08-17 |
The Board Of Regents Of The University Of Texas System |
Unsaturated dendrimers compositions,related formulations, and methods of use thereof
|
|
CN115427432A
(zh)
*
|
2021-02-10 |
2022-12-02 |
斯微(上海)生物科技股份有限公司 |
一种治疗或者预防冠状病毒病突变株的疫苗试剂
|
|
EP4291165A1
(en)
|
2021-02-12 |
2023-12-20 |
ModernaTX, Inc. |
Lnp compositions comprising payloads for in vivo therapy
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
IL306007A
(en)
|
2021-03-23 |
2023-11-01 |
Recode Therapeutics Inc |
Polynucleotide preparations, related formulations and methods of using them
|
|
EP4313115A1
(en)
|
2021-03-25 |
2024-02-07 |
Translate Bio, Inc. |
Optimized nucleotide sequences encoding the extracellular domain of human ace2 protein or a portion thereof
|
|
JP2024512669A
(ja)
|
2021-03-31 |
2024-03-19 |
フラグシップ パイオニアリング イノベーションズ ブイ，インコーポレーテッド |
タノトランスミッションポリペプチド及び癌の処置におけるそれらの使用
|
|
BR112023021477A2
(pt)
|
2021-04-17 |
2024-01-30 |
Intellia Therapeutics Inc |
Composições de nanopartículas lipídicas
|
|
JP2024516376A
(ja)
|
2021-04-17 |
2024-04-15 |
インテリア セラピューティクス，インコーポレーテッド |
Ｄｎａ依存性プロテインキナーゼの阻害剤ならびにその組成物及び使用
|
|
TW202308596A
(zh)
|
2021-04-17 |
2023-03-01 |
美商英特利亞醫療公司 |
脂質奈米顆粒組合物
|
|
EP4326338A1
(en)
|
2021-04-19 |
2024-02-28 |
Translate Bio, Inc. |
Improved compositions for delivery of mrna
|
|
KR20240012370A
(ko)
|
2021-04-20 |
2024-01-29 |
안자리움 바이오사이언시스 아게 |
아밀로-알파-1, 6-글루코시다제, 4-알파-글루카노트랜스퍼라제를 인코딩하는 dna 분자의 조성물, 이를 제조하는 방법 및 이를 사용하는 방법
|
|
MX2023012605A
(es)
|
2021-04-23 |
2024-02-23 |
Ganna Bio Inc |
Acidos nucleicos modificados con glicano, metodos de preparacion y usos terapeuticos.
|
|
WO2022232286A1
(en)
|
2021-04-27 |
2022-11-03 |
Generation Bio Co. |
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof
|
|
MX2023012643A
(es)
|
2021-04-27 |
2024-01-05 |
Generation Bio Co |
Vectores de adn no virales que expresan anticuerpos terapéuticos y usos de estos.
|
|
WO2022233291A1
(en)
*
|
2021-05-06 |
2022-11-10 |
Stemirna Therapeutics Co., Ltd. |
A lipid
|
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
|
US20240277616A1
(en)
*
|
2021-05-07 |
2024-08-22 |
Carnegie Mellon University |
Lipid Nanoparticle-Mediated mRNA Delivery to the Pancreas
|
|
US20220363937A1
(en)
|
2021-05-14 |
2022-11-17 |
Armstrong World Industries, Inc. |
Stabilization of antimicrobial coatings
|
|
CA3219932A1
(en)
|
2021-06-10 |
2022-12-15 |
Robert Alexander WESSELHOEFT |
Circular rna compositions and methods
|
|
CN113387825A
(zh)
*
|
2021-06-10 |
2021-09-14 |
福州大学 |
长链烷基酯胺类化合物或含氟长链烷基酯胺类化合物及其公斤级制备方法
|
|
EP4355727A1
(en)
|
2021-06-14 |
2024-04-24 |
Generation Bio Co. |
Cationic lipids and compositions thereof
|
|
US20250001002A1
(en)
|
2021-07-01 |
2025-01-02 |
Translate Bio, Inc. |
Compositions for delivery of mrna
|
|
CN114149337B
(zh)
*
|
2021-07-07 |
2022-04-29 |
天津键凯科技有限公司 |
一种用于核酸递送的新型可电离脂质及其lnp组合物
|
|
CN115611757A
(zh)
*
|
2021-07-16 |
2023-01-17 |
江苏慧聚药业股份有限公司 |
mRNA传递剂的合成
|
|
EP4377457A1
(en)
|
2021-07-26 |
2024-06-05 |
Flagship Pioneering Innovations VI, LLC |
Trem compositions and uses thereof
|
|
US12251471B2
(en)
*
|
2021-07-26 |
2025-03-18 |
Oregon State University |
Inhalable therapeutics
|
|
JP2024530672A
(ja)
*
|
2021-08-11 |
2024-08-23 |
アールエヌエーイミューン、インコーポレイテッド |
新規なコロナウイルス感染症に対するｍＲＮＡワクチンの組成物および方法
|
|
CN115703713B
(zh)
*
|
2021-08-13 |
2025-06-10 |
广州谷森制药有限公司 |
阳离子脂质化合物
|
|
CN115703714B
(zh)
*
|
2021-08-13 |
2025-06-10 |
广州谷森制药有限公司 |
阳离子脂质化合物
|
|
WO2023023055A1
(en)
|
2021-08-16 |
2023-02-23 |
Renagade Therapeutics Management Inc. |
Compositions and methods for optimizing tropism of delivery systems for rna
|
|
WO2023031394A1
(en)
|
2021-09-03 |
2023-03-09 |
CureVac SE |
Novel lipid nanoparticles for delivery of nucleic acids
|
|
WO2023044333A1
(en)
|
2021-09-14 |
2023-03-23 |
Renagade Therapeutics Management Inc. |
Cyclic lipids and methods of use thereof
|
|
JP2024534697A
(ja)
|
2021-09-14 |
2024-09-20 |
レナゲード セラピューティクス マネージメント インコーポレイテッド |
非環状脂質及びその使用方法
|
|
EP4464783A3
(en)
|
2021-09-17 |
2025-01-22 |
Flagship Pioneering Innovations VI, LLC |
Compositions and methods for producing circular polyribonucleotides
|
|
WO2023056033A1
(en)
|
2021-09-30 |
2023-04-06 |
Orna Therapeutics, Inc. |
Lipid nanoparticle compositions for delivering circular polynucleotides
|
|
EP4408871A1
(en)
*
|
2021-10-01 |
2024-08-07 |
ModernaTX, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
|
EP4412711A1
(en)
|
2021-10-07 |
2024-08-14 |
Avacta Life Sciences Limited |
Serum half-life extended pd-l1 binding polypeptides
|
|
WO2023057567A1
(en)
|
2021-10-07 |
2023-04-13 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
|
AR127312A1
(es)
|
2021-10-08 |
2024-01-10 |
Suzhou Abogen Biosciences Co Ltd |
Compuestos lipídicos ycomposiciones de nanopartículas lipídicas
|
|
JP2024536406A
(ja)
*
|
2021-10-08 |
2024-10-04 |
スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド |
脂質化合物及び脂質ナノ粒子組成物
|
|
US20250281583A1
(en)
|
2021-10-13 |
2025-09-11 |
Modernatx, Inc. |
Composition of mrna-encoded il15 fusion proteins and methods of use thereof
|
|
TW202322826A
(zh)
|
2021-10-18 |
2023-06-16 |
美商旗艦先鋒創新有限責任公司 |
用於純化多核糖核苷酸之組成物及方法
|
|
EP4419081A1
(en)
|
2021-10-22 |
2024-08-28 |
Sail Biomedicines, Inc. |
Mrna vaccine composition
|
|
EP4422698A1
(en)
|
2021-10-29 |
2024-09-04 |
CureVac SE |
Improved circular rna for expressing therapeutic proteins
|
|
WO2023076733A1
(en)
|
2021-11-01 |
2023-05-04 |
Dana-Farber Cancer Institute, Inc. |
Biologically selected nucleic acid artificial mini-proteome libraries
|
|
US20250043269A1
(en)
|
2021-11-03 |
2025-02-06 |
The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glad |
Precise Genome Editing Using Retrons
|
|
KR20240107139A
(ko)
|
2021-11-08 |
2024-07-08 |
오나 테라퓨틱스, 인코포레이티드 |
원형 폴리뉴클레오티드를 전달하기 위한 지질 나노입자 조성물
|
|
WO2023086893A1
(en)
|
2021-11-10 |
2023-05-19 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
|
CN118488834A
(zh)
|
2021-11-23 |
2024-08-13 |
赛欧生物医药股份有限公司 |
细菌源性脂质组合物和其用途
|
|
IL313004A
(en)
|
2021-11-24 |
2024-07-01 |
Flagship Pioneering Innovations Vi Llc |
Coronavirus immunogen compositions and their uses
|
|
EP4436598A2
(en)
|
2021-11-24 |
2024-10-02 |
Flagship Pioneering Innovations VI, LLC |
Immunogenic compositions and their uses
|
|
IL312799A
(en)
|
2021-11-24 |
2024-07-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions of varicella-zoster virus and uses thereof
|
|
US12186387B2
(en)
|
2021-11-29 |
2025-01-07 |
BioNTech SE |
Coronavirus vaccine
|
|
AR127892A1
(es)
|
2021-12-10 |
2024-03-06 |
Modernatx Inc |
Compuestos y composiciones para la administración de agentes terapéuticos
|
|
KR20240123832A
(ko)
|
2021-12-16 |
2024-08-14 |
아퀴타스 테라퓨틱스 인크. |
지질 나노입자 제형에 사용하기 위한 지질
|
|
US20250049728A1
(en)
|
2021-12-16 |
2025-02-13 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticles
|
|
EP4448758A1
(en)
|
2021-12-17 |
2024-10-23 |
Flagship Pioneering Innovations VI, LLC |
Methods for enrichment of circular rna under denaturing conditions
|
|
CA3241503A1
(en)
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Nanomaterials comprising tetravalent lipid compounds
|
|
JP2025501731A
(ja)
|
2021-12-20 |
2025-01-23 |
ビーム セラピューティクス インク． |
イオン化可能なアミン脂質及び脂質ナノ粒子
|
|
AU2022421841A1
(en)
|
2021-12-20 |
2024-06-27 |
Sail Biomedicines, Inc. |
Mrna therapeutic compositions
|
|
EP4452942A1
(en)
|
2021-12-20 |
2024-10-30 |
Beam Therapeutics Inc. |
Nanomaterials comprising disulfides
|
|
EP4452925A1
(en)
|
2021-12-20 |
2024-10-30 |
Beam Therapeutics Inc. |
Nanomaterial comprising diamines
|
|
EP4452930A1
(en)
|
2021-12-20 |
2024-10-30 |
Beam Therapeutics Inc. |
Ionizable amine and ester lipids and lipid nanoparticles
|
|
CA3241061A1
(en)
|
2021-12-22 |
2023-06-29 |
Alexandra Sophie DE BOER |
Compositions and methods for purifying polyribonucleotides
|
|
MX2024007870A
(es)
|
2021-12-23 |
2024-08-15 |
Flagship Pioneering Innovations Vi Llc |
Polirribonucleotidos circulares que codifican polipeptidos antifusogenicos.
|
|
CA3243054A1
(en)
|
2021-12-23 |
2025-04-08 |
Renagade Therapeutics Management Inc. |
Constrained Lipids and Associated Utilization Processes
|
|
CA3242974A1
(en)
|
2021-12-29 |
2023-07-06 |
Shanghai Senhui Medicine Co., Ltd. |
LIPID AND COMPOSITION USED FOR ADMINISTRATION
|
|
WO2023126006A1
(zh)
*
|
2021-12-31 |
2023-07-06 |
厦门赛诺邦格生物科技股份有限公司 |
一种侧链含功能性基团的阳离子脂质及其应用
|
|
CN114957027B
(zh)
*
|
2022-01-13 |
2023-05-19 |
北京悦康科创医药科技股份有限公司 |
一种阳离子脂质化合物、包含其的组合物及用途
|
|
US20250381294A1
(en)
|
2022-01-14 |
2025-12-18 |
Anjarium Biosciences Ag |
Compositions of DNA Molecules Encoding Factor VIII, Methods of Making Thereof, and Methods of Use Thereof
|
|
JP2025502986A
(ja)
*
|
2022-01-19 |
2025-01-30 |
スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド |
脂質化合物及び脂質ナノ粒子組成物
|
|
AU2023210304A1
(en)
|
2022-01-21 |
2024-07-11 |
Orna Therapeutics, Inc. |
Systemic administration of circular rna polynucleotides encoding muscle proteins or protein complexes
|
|
WO2023141602A2
(en)
|
2022-01-21 |
2023-07-27 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
|
WO2023144330A1
(en)
|
2022-01-28 |
2023-08-03 |
CureVac SE |
Nucleic acid encoded transcription factor inhibitors
|
|
US20250332112A1
(en)
*
|
2022-01-31 |
2025-10-30 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
|
EP4475882A1
(en)
|
2022-02-09 |
2024-12-18 |
ModernaTX, Inc. |
Mucosal administration methods and formulations
|
|
CN114456081B
(zh)
*
|
2022-02-15 |
2025-03-11 |
浙江汇科泽华生物技术有限公司 |
一种可离子化脂质及其制备方法和应用
|
|
WO2023156487A1
(en)
|
2022-02-15 |
2023-08-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for modulating tear film composition to treat corneal defects
|
|
TW202345864A
(zh)
*
|
2022-02-18 |
2023-12-01 |
美商現代公司 |
編碼檢查點癌症疫苗之ｍＲＮＡ及其用途
|
|
CN119072463A
(zh)
*
|
2022-02-24 |
2024-12-03 |
维硕公司 |
新型可电离阳离子脂质
|
|
KR20240161965A
(ko)
|
2022-03-14 |
2024-11-13 |
제너레이션 바이오 컴퍼니 |
이종 프라임 부스트 백신 조성물 및 사용 방법
|
|
CN116813493A
(zh)
*
|
2022-03-21 |
2023-09-29 |
苏州科锐迈德生物医药科技有限公司 |
一种脂质化合物及基于其的脂质载体、核酸脂质纳米粒组合物和药物制剂
|
|
US12064511B2
(en)
|
2022-03-24 |
2024-08-20 |
The Regents Of The University Of California |
Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy
|
|
KR20240166554A
(ko)
|
2022-03-25 |
2024-11-26 |
세일 바이오메디슨스, 인크. |
신규한 이온화 가능 지질 및 지질 나노입자, 및 이를 사용하는 방법
|
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
|
CA3255619A1
(en)
|
2022-04-07 |
2023-10-12 |
Renagade Therapeutics Management Inc. |
CYCLIC LIPIDS AND LIPID NANOPARTICLES (LPNs) FOR THE SUPPLY OF NUCLEIC ACIDS OR PEPTIDES INTENDED FOR USE IN VACCINATION AGAINST INFECTIOUS AGENTS
|
|
TW202404568A
(zh)
|
2022-04-07 |
2024-02-01 |
美商Ｒｎａ免疫公司 |
用於藥物遞送之化合物及組合物
|
|
WO2023196634A2
(en)
|
2022-04-08 |
2023-10-12 |
Flagship Pioneering Innovations Vii, Llc |
Vaccines and related methods
|
|
AU2023260227A1
(en)
|
2022-04-27 |
2024-11-21 |
Shanghai Regenelead Therapies Co., Ltd |
Nucleic acid construct and use thereof
|
|
EP4522743A1
(en)
|
2022-05-09 |
2025-03-19 |
Flagship Pioneering Innovations VI, LLC |
Trem compositions and methods of use for treating proliferative disorders
|
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
|
IL316630A
(en)
|
2022-05-13 |
2024-12-01 |
BioNTech SE |
HIV-targeted RNA complexes
|
|
JP2025516638A
(ja)
|
2022-05-13 |
2025-05-30 |
フラッグシップ パイオニアリング イノベーションズ セブン，エルエルシー |
二本鎖ｄｎａ組成物及び関連する方法
|
|
WO2023217267A1
(zh)
|
2022-05-13 |
2023-11-16 |
上海瑞宏迪医药有限公司 |
包含utr的核酸构建体及其应用
|
|
JP2025522297A
(ja)
|
2022-05-25 |
2025-07-15 |
ビオンテック エスエー |
サルポックス抗原の送達のためのｒｎａ組成物及び関連する方法
|
|
CN119212720A
(zh)
|
2022-05-25 |
2024-12-27 |
库瑞瓦格欧洲股份公司 |
编码大肠杆菌FimH抗原性多肽的基于核酸的疫苗
|
|
JP2025518221A
(ja)
|
2022-05-30 |
2025-06-12 |
ビオンテック・ソシエタス・エウロパエア |
核酸の送達のための複合体
|
|
WO2023239756A1
(en)
|
2022-06-07 |
2023-12-14 |
Generation Bio Co. |
Lipid nanoparticle compositions and uses thereof
|
|
CN117285474A
(zh)
*
|
2022-06-16 |
2023-12-26 |
南京诺唯赞生物科技股份有限公司 |
一类新的脂质化合物及其用途
|
|
WO2023250112A1
(en)
|
2022-06-22 |
2023-12-28 |
Flagship Pioneering Innovations Vi, Llc |
Compositions of modified trems and uses thereof
|
|
US12297285B2
(en)
|
2022-06-24 |
2025-05-13 |
Orna Therapeutics, Inc. |
Circular RNA encoding chimeric antigen receptors targeting BCMA
|
|
WO2024002985A1
(en)
|
2022-06-26 |
2024-01-04 |
BioNTech SE |
Coronavirus vaccine
|
|
EP4558624A2
(en)
|
2022-07-18 |
2025-05-28 |
Renagade Therapeutics Management Inc. |
Gene editing components, systems, and methods of use
|
|
JP2025528020A
(ja)
|
2022-07-20 |
2025-08-26 |
ビーム セラピューティクス インク． |
トリオールを含むナノ材料
|
|
AU2023320333A1
(en)
|
2022-08-01 |
2025-01-16 |
Flagship Pioneering Innovations Vii, Llc |
Immunomodulatory proteins and related methods
|
|
WO2024031051A1
(en)
*
|
2022-08-05 |
2024-02-08 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|
|
CN119654136A
(zh)
*
|
2022-08-09 |
2025-03-18 |
斯微(上海)生物科技股份有限公司 |
一种脂质组合物
|
|
WO2024035932A1
(en)
|
2022-08-11 |
2024-02-15 |
RNAimmune, Inc. |
Lyophilized nanoparticle compositions and methods of use thereof
|
|
EP4569112A1
(en)
|
2022-08-12 |
2025-06-18 |
Remix Therapeutics Inc. |
Methods and compositions for modulating splicing at alternative splice sites
|
|
WO2024040222A1
(en)
|
2022-08-19 |
2024-02-22 |
Generation Bio Co. |
Cleavable closed-ended dna (cedna) and methods of use thereof
|
|
EP4577519A1
(en)
|
2022-08-23 |
2025-07-02 |
ModernaTX, Inc. |
Methods for purification of ionizable lipids
|
|
WO2024044723A1
(en)
|
2022-08-25 |
2024-02-29 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
|
KR20250056256A
(ko)
|
2022-08-31 |
2025-04-25 |
세일 바이오메디슨스, 인크. |
신규 이온화성 지질 및 지질 나노입자, 그리고 이의 사용 방법
|
|
CN120152962A
(zh)
|
2022-09-06 |
2025-06-13 |
国立大学法人九州大学 |
脂质纳米粒子
|
|
CN120152960A
(zh)
*
|
2022-09-08 |
2025-06-13 |
纳米科技制药公司 |
用于细胞内递送核酸类药物的化合物和其组合物及其方法
|
|
CN120518491A
(zh)
*
|
2022-09-09 |
2025-08-22 |
厦门赛诺邦格生物科技股份有限公司 |
一种碳核阳离子脂质
|
|
CN115197431B
(zh)
*
|
2022-09-15 |
2022-11-29 |
清华大学 |
脂质偶联完全可降解水溶性聚合物的合成及应用
|
|
EP4342460A1
(en)
|
2022-09-21 |
2024-03-27 |
NovoArc GmbH |
Lipid nanoparticle with nucleic acid cargo
|
|
WO2024077191A1
(en)
|
2022-10-05 |
2024-04-11 |
Flagship Pioneering Innovations V, Inc. |
Nucleic acid molecules encoding trif and additionalpolypeptides and their use in treating cancer
|
|
GB202215200D0
(en)
|
2022-10-14 |
2022-11-30 |
Mercurna B V |
Novel ionizable lipids
|
|
DE202023106198U1
(de)
|
2022-10-28 |
2024-03-21 |
CureVac SE |
Impfstoff auf Nukleinsäurebasis
|
|
WO2024089229A1
(en)
|
2022-10-28 |
2024-05-02 |
CureVac SE |
Improved formulations comprising lipid-based carriers encapsulating rna
|
|
EP4612296A1
(en)
|
2022-10-31 |
2025-09-10 |
Flagship Pioneering Innovations VI, LLC |
Compositions and methods for purifying polyribonucleotides
|
|
WO2024097259A1
(en)
|
2022-11-01 |
2024-05-10 |
RNAimmune, Inc. |
Composition and methods for mrna vaccines against novel omicron coronavirus infections
|
|
WO2024102730A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and nanoparticle compositions for delivering polynucleotides
|
|
WO2024102762A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
|
AR131008A1
(es)
|
2022-11-08 |
2025-02-05 |
Flagship Pioneering Innovations Vi Llc |
Composiciones y métodos para producir polirribonucleótidos circulares
|
|
TW202428289A
(zh)
|
2022-11-08 |
2024-07-16 |
美商歐納醫療公司 |
環狀rna組合物
|
|
CN120359023A
(zh)
|
2022-11-10 |
2025-07-22 |
赛欧生物医药股份有限公司 |
包含脂质纳米颗粒或脂质重构的天然信使包的rna组合物
|
|
WO2024107702A1
(en)
*
|
2022-11-14 |
2024-05-23 |
Board Of Regents, The University Of Texas System |
Aerosolized lipid nanoparticles and uses thereof
|
|
JP2025538523A
(ja)
|
2022-11-21 |
2025-11-28 |
トランスレイト バイオ， インコーポレイテッド |
メッセンジャーｒｎａの乾燥粉末製剤の組成物及びその使用方法
|
|
CN120641465A
(zh)
|
2022-12-01 |
2025-09-12 |
世代生物公司 |
新颖的聚甘油缀合脂质和包含其的脂质纳米颗粒组合物
|
|
KR20250114116A
(ko)
|
2022-12-01 |
2025-07-28 |
제너레이션 바이오 컴퍼니 |
세포 표적화를 위한 스텔스 지질 나노입자 조성물
|
|
EP4626402A1
(en)
|
2022-12-01 |
2025-10-08 |
Generation Bio Co. |
Lipid nanoparticles comprising nucleic acids and lipid-anchored polymers
|
|
KR20250129819A
(ko)
|
2022-12-01 |
2025-08-29 |
제너레이션 바이오 컴퍼니 |
핵산, 이온화 가능한 지질, 스테롤, 지질에 고정된 중합체, 및 헬퍼 지질을 포함하는 지질 나노입자 및 이의 용도
|
|
EP4626859A1
(en)
*
|
2022-12-02 |
2025-10-08 |
Prime Medicine, Inc. |
Lipid nanoparticle (lnp) delivery systems and formulations
|
|
WO2024119037A1
(en)
*
|
2022-12-02 |
2024-06-06 |
University Of Cincinnati |
Novel ionizable lipids and lipid nanoparticles comprising the same
|
|
WO2024123978A1
(en)
|
2022-12-08 |
2024-06-13 |
Modernatx, Inc. |
Ionizable lipids with malonate tails
|
|
WO2024123633A1
(en)
|
2022-12-08 |
2024-06-13 |
Recode Therapeutics, Inc. |
Lipid nanoparticle compositions and uses thereof
|
|
TW202430215A
(zh)
|
2022-12-14 |
2024-08-01 |
美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 |
用於將治療劑遞送至骨之組成物和方法
|
|
EP4633673A1
(en)
|
2022-12-15 |
2025-10-22 |
Sanofi Pasteur Inc. |
Mrna encoding influenza virus-like particle
|
|
TW202438514A
(zh)
|
2022-12-20 |
2024-10-01 |
法商賽諾菲公司 |
鼻病毒mrna疫苗
|
|
EP4637718A1
(en)
*
|
2022-12-21 |
2025-10-29 |
Suzhou Abogen Biosciences Co., Ltd. |
Lipid nanoparticles comprising sterol-modified phospholipids
|
|
WO2024138189A2
(en)
|
2022-12-22 |
2024-06-27 |
Intellia Therapeutics, Inc. |
Methods for analyzing nucleic acid cargos of lipid nucleic acid assemblies
|
|
EP4637728A1
(en)
|
2022-12-23 |
2025-10-29 |
BioNTech Delivery Technologies GmbH |
Composition
|
|
CN121127490A
(zh)
|
2022-12-28 |
2025-12-12 |
生物技术欧洲股份公司 |
靶向hiv的rna组合物
|
|
WO2024141784A2
(en)
|
2022-12-29 |
2024-07-04 |
Popvax Private Limited |
Broadly protective betacoronavirus vaccines and compositions
|
|
US20240263196A1
(en)
*
|
2022-12-29 |
2024-08-08 |
Life Technologies Corporation |
Lipid Compositions and Methods for Delivery to Immune Cells
|
|
EP4644552A1
(en)
|
2022-12-29 |
2025-11-05 |
Rinuagene Biotechnology Co., Ltd. |
Polynucleotide molecule for preventing or treating hpv infection-related diseases
|
|
WO2024141786A2
(en)
|
2022-12-29 |
2024-07-04 |
Popvax Private Limited |
Multitarget vaccines and therapeutics
|
|
WO2024147060A1
(en)
*
|
2023-01-05 |
2024-07-11 |
Celon Pharma S.A. |
Novel ionizable lipid compounds for nucleic acid delivery
|
|
CN115677518B
(zh)
|
2023-01-05 |
2023-04-14 |
北京悦康科创医药科技股份有限公司 |
用于递送核酸的可电离阳离子脂质化合物和组合物及用途
|
|
CN116178193B
(zh)
|
2023-01-05 |
2023-07-28 |
北京悦康科创医药科技股份有限公司 |
高效低毒且稳定性表达的阳离子脂质化合物及其组合物
|
|
CN115745820B
(zh)
*
|
2023-01-05 |
2023-04-28 |
北京悦康科创医药科技股份有限公司 |
长效低毒的新型阳离子脂质化合物及其组合物
|
|
US20240238473A1
(en)
|
2023-01-09 |
2024-07-18 |
Beth Israel Deaconess Medical Center, Inc. |
Recombinant nucleic acid molecules and their use in wound healing
|
|
EP4648794A2
(en)
|
2023-01-09 |
2025-11-19 |
Flagship Pioneering Innovations VII, LLC |
Vaccines and related methods
|
|
WO2024151685A1
(en)
|
2023-01-09 |
2024-07-18 |
Beth Israel Deaconess Medical Center, Inc. |
Recombinant nucleic acid molecules and their use in wound healing
|
|
WO2024151687A1
(en)
|
2023-01-09 |
2024-07-18 |
Flagship Pioneering Innovations V, Inc. |
Genetic switches and their use in treating cancer
|
|
AU2024212425A1
(en)
|
2023-01-27 |
2025-08-07 |
Sail Biomedicines, Inc. |
A modified lipid composition and uses thereof
|
|
WO2024161249A1
(en)
*
|
2023-01-31 |
2024-08-08 |
Pfizer Inc. |
Lipid compounds and uses thereof
|
|
TW202438515A
(zh)
|
2023-02-06 |
2024-10-01 |
美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 |
免疫調節組合物及相關方法
|
|
CN115784921B
(zh)
|
2023-02-08 |
2023-05-05 |
北京悦康科创医药科技股份有限公司 |
肝外靶向高效低毒的阳离子脂质化合物及其组合物
|
|
EP4665736A2
(en)
*
|
2023-02-13 |
2025-12-24 |
Flagship Pioneering Innovations VII, LLC |
Cleavable linker-containing ionizable lipids and lipid carriers for therapeutic compositions
|
|
IL322201A
(en)
|
2023-02-17 |
2025-09-01 |
Flagship Pioneering Innovations Vii Llc |
DNA structures containing modified uracil
|
|
EP4665856A2
(en)
|
2023-02-17 |
2025-12-24 |
Flagship Pioneering Innovations VII, LLC |
Dna compositions comprising modified cytosine
|
|
WO2024175604A1
(en)
|
2023-02-21 |
2024-08-29 |
Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical composition for the treatment of sanfilippo syndrome type iiib
|
|
WO2024178305A1
(en)
|
2023-02-24 |
2024-08-29 |
Modernatx, Inc. |
Compositions of mrna-encoded il-15 fusion proteins and methods of use thereof for treating cancer
|
|
AU2024233180A1
(en)
|
2023-03-08 |
2025-09-25 |
CureVac SE |
Novel lipid nanoparticle formulations for delivery of nucleic acids
|
|
AU2024235803A1
(en)
|
2023-03-15 |
2025-09-25 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising polyribonucleotides and uses thereof
|
|
AU2024236558A1
(en)
|
2023-03-15 |
2025-10-09 |
Renagade Therapeutics Management Inc. |
Delivery of gene editing systems and methods of use thereof
|
|
AU2024234874A1
(en)
|
2023-03-15 |
2025-10-09 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2024192422A1
(en)
|
2023-03-15 |
2024-09-19 |
Flagship Pioneering Innovations Vi, Llc |
Immunogenic compositions and uses thereof
|
|
KR20240159310A
(ko)
*
|
2023-04-28 |
2024-11-05 |
주식회사 메디치바이오 |
신규한 이온화지질을 이용한 지질나노입자 조성물
|
|
WO2024197310A1
(en)
|
2023-03-23 |
2024-09-26 |
Modernatx, Inc. |
Peg targeting compounds for delivery of therapeutics
|
|
WO2024197307A1
(en)
|
2023-03-23 |
2024-09-26 |
Modernatx, Inc. |
Peg targeting compounds for delivery of therapeutics
|
|
WO2024197309A1
(en)
|
2023-03-23 |
2024-09-26 |
Modernatx, Inc. |
Peg targeting compounds for delivery of therapeutics
|
|
WO2024205657A2
(en)
|
2023-03-29 |
2024-10-03 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
|
WO2024200823A1
(en)
|
2023-03-30 |
2024-10-03 |
Ose Immunotherapeutics |
Lipid-based nanoparticle targeted at activated immune cells for the expression of immune cell enhancing molecule and use thereof
|
|
WO2024200820A1
(en)
|
2023-03-30 |
2024-10-03 |
Ose Immunotherapeutics |
Method of synthesis of targeted lipid nanoparticle and uses thereof
|
|
WO2024216128A1
(en)
|
2023-04-12 |
2024-10-17 |
Flagship Pioneering Innovations Vi, Llc |
Trems for use in correction of missense mutations
|
|
AU2024255972A1
(en)
|
2023-04-12 |
2025-10-23 |
Flagship Pioneering Innovations Vi, Llc |
Modified trems, compositions, and related methods thereof
|
|
AU2024256347A1
(en)
|
2023-04-17 |
2025-11-27 |
Sanofi Pasteur Inc. |
Reconstitutable dry powder formulations and methods of use thereof
|
|
WO2024220625A1
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
|
|
WO2024220712A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Vaccine compositions
|
|
WO2024220752A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Rna therapeutic compositions
|
|
WO2024220746A2
(en)
|
2023-04-21 |
2024-10-24 |
Flagship Pioneering Innovations Vii, Llc |
Rnai agents targeting fatty acid synthase and related methods
|
|
CN117384055B
(zh)
*
|
2023-04-27 |
2024-11-19 |
仁景(苏州)生物科技有限公司 |
用于递送治疗剂的可电离脂质及其用途
|
|
CN121039098A
(zh)
*
|
2023-04-28 |
2025-11-28 |
日东电工株式会社 |
脂质、包含其的药物组合物、和递送活性药物成分的方法
|
|
AU2024269222A1
(en)
|
2023-05-05 |
2025-10-09 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
WO2024230934A1
(en)
|
2023-05-11 |
2024-11-14 |
CureVac SE |
Therapeutic nucleic acid for the treatment of ophthalmic diseases
|
|
WO2024236336A1
(en)
|
2023-05-17 |
2024-11-21 |
Institut National de la Santé et de la Recherche Médicale |
Lipc variant in the treatment of hypercholesterolemia and atherosclerotic cardiovascular disease
|
|
WO2024243031A2
(en)
|
2023-05-19 |
2024-11-28 |
Intellia Therapeutics, Inc. |
Ionizable amine lipids
|
|
WO2024249954A1
(en)
|
2023-05-31 |
2024-12-05 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2024258829A1
(en)
|
2023-06-12 |
2024-12-19 |
Flagship Pioneering Innovations Vii, Llc |
Sars-cov-2 vaccine compositions and related methods
|
|
WO2024259373A1
(en)
|
2023-06-14 |
2024-12-19 |
Modernatx, Inc. |
Compounds and compositions for delivery of therapeutic agents
|
|
US20240423915A1
(en)
*
|
2023-06-16 |
2024-12-26 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticles
|
|
WO2024260570A1
(en)
|
2023-06-23 |
2024-12-26 |
CureVac SE |
Nucleic acid encoded antibodies
|
|
WO2025006684A1
(en)
|
2023-06-28 |
2025-01-02 |
Flagship Pioneering Innovations Vi, Llc |
Circular polyribonucleotides encoding antifusogenic polypeptides
|
|
WO2025003760A1
(en)
|
2023-06-28 |
2025-01-02 |
Sanofi |
Sterol analogs in lipid nanoparticle formulations
|
|
WO2025007148A1
(en)
|
2023-06-30 |
2025-01-02 |
Orna Therapeutics, Inc. |
Polymer lipid nanoparticle compositions for delivering circular polynucleotides
|
|
WO2025011529A2
(en)
|
2023-07-07 |
2025-01-16 |
Shanghai Circode Biomed Co., Ltd. |
Circular rna vaccines for seasonal flu and methods of uses
|
|
TW202516001A
(zh)
|
2023-07-25 |
2025-04-16 |
美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 |
Ｃａｓ內切酶及相關方法
|
|
WO2025027116A1
(en)
|
2023-08-01 |
2025-02-06 |
Institut Curie |
Nanoparticles comprising nucleic acid sequences encoding cyclic gmp-amp synthase
|
|
WO2025027576A2
(en)
|
2023-08-03 |
2025-02-06 |
BioNTech SE |
Rna compositions targeting hiv
|
|
WO2025027579A2
(en)
|
2023-08-03 |
2025-02-06 |
BioNTech SE |
Rna compositions targeting hiv
|
|
WO2025032158A1
(en)
|
2023-08-08 |
2025-02-13 |
Institut National de la Santé et de la Recherche Médicale |
Method to treat tauopathies
|
|
WO2025038864A1
(en)
*
|
2023-08-16 |
2025-02-20 |
Beam Therapeutics Inc. |
Ionizable lipids with linear head groups
|
|
WO2025042786A1
(en)
|
2023-08-18 |
2025-02-27 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
CN117088820B
(zh)
*
|
2023-08-18 |
2025-11-28 |
苏州信使生物科技有限公司 |
一种新型阳离子lnp递送系统及制备方法
|
|
WO2025049690A1
(en)
|
2023-08-29 |
2025-03-06 |
Orna Therapeutics, Inc. |
Circular polyethylene glycol lipids
|
|
WO2025045142A1
(en)
|
2023-08-29 |
2025-03-06 |
Shanghai Circode Biomed Co., Ltd. |
Circular rna encoding vegf polypeptides, formulations, and methods of uses
|
|
WO2025048714A1
(en)
*
|
2023-08-30 |
2025-03-06 |
Agency For Science, Technology And Research |
A compound for preparing lipid nanoparticles encapsulating an agent, nanoparticle composition comprising said compound and related methods thereof
|
|
WO2025049959A2
(en)
|
2023-09-01 |
2025-03-06 |
Renagade Therapeutics Management Inc. |
Gene editing systems, compositions, and methods for treatment of vexas syndrome
|
|
WO2025046121A1
(en)
|
2023-09-01 |
2025-03-06 |
Novoarc Gmbh |
Lipid nanoparticle with nucleic acid cargo and ionizable lipid
|
|
WO2025054236A2
(en)
|
2023-09-06 |
2025-03-13 |
Flagship Pioneering Innovations Vii, Llc |
Sars-cov-2 vaccine compositions and related methods
|
|
WO2025052180A2
(en)
|
2023-09-07 |
2025-03-13 |
Axelyf ehf. |
Lipids and lipid nanoparticles
|
|
CN119591513A
(zh)
*
|
2023-09-11 |
2025-03-11 |
苏州星核迪赛生物技术有限公司 |
局部递送药物的材料及其应用
|
|
WO2025062311A2
(en)
|
2023-09-18 |
2025-03-27 |
University Of The Witwatersrand, Johannesburg |
A method of manufacturing precursor compounds for manufacturing cannabinoids and/or methods of manufacturing cannabinoids
|
|
WO2025064475A2
(en)
|
2023-09-18 |
2025-03-27 |
Flagship Pioneering Innovations Vii, Llc |
Ionizable lipidoid compositions and therapeutic uses thereof
|
|
WO2025064850A1
(en)
|
2023-09-22 |
2025-03-27 |
BioNTech SE |
Rna constructs with n-terminal degrons to enhance an immune response
|
|
WO2025072383A1
(en)
|
2023-09-25 |
2025-04-03 |
The Broad Institute, Inc. |
Viral open reading frames, uses thereof, and methods of detecting the same
|
|
WO2025072331A1
(en)
|
2023-09-26 |
2025-04-03 |
Flagship Pioneering Innovations Vii, Llc |
Cas nucleases and related methods
|
|
WO2025073890A1
(en)
|
2023-10-06 |
2025-04-10 |
Institut National de la Santé et de la Recherche Médicale |
Method to capture circulating tumor extracellular vesicles
|
|
WO2025080867A1
(en)
*
|
2023-10-10 |
2025-04-17 |
The Board Of Regents Of The University Of Texas System |
Ionizable lipids for improved mrna delivery
|
|
WO2025081002A1
(en)
|
2023-10-11 |
2025-04-17 |
RNAimmune, Inc. |
Ionizable lipids for the delivery of nucleic acids
|
|
WO2025081042A1
(en)
|
2023-10-12 |
2025-04-17 |
Renagade Therapeutics Management Inc. |
Nickase-retron template-based precision editing system and methods of use
|
|
TW202530174A
(zh)
*
|
2023-10-19 |
2025-08-01 |
大陸商仁景（蘇州）生物科技有限公司 |
用於遞送的脂質化合物及脂質奈米顆粒
|
|
CN119912351A
(zh)
*
|
2023-10-30 |
2025-05-02 |
广州市锐博生物科技有限公司 |
脂质化合物及其组合物
|
|
WO2025096681A1
(en)
*
|
2023-10-31 |
2025-05-08 |
Tiba Biotech Llc |
Novel gene delivery agents
|
|
WO2025096807A2
(en)
|
2023-10-31 |
2025-05-08 |
Flagship Pioneering Innovations Vii, Llc |
Novel therapeutic dna forms
|
|
WO2025097055A2
(en)
|
2023-11-02 |
2025-05-08 |
The Broad Institute, Inc. |
Compositions and methods of use of t cells in immunotherapy
|
|
WO2025101501A1
(en)
|
2023-11-07 |
2025-05-15 |
Orna Therapeutics, Inc. |
Circular rna compositions
|
|
WO2025103803A1
(en)
|
2023-11-13 |
2025-05-22 |
CureVac SE |
Immunotherapy against neuronal and brain tumors
|
|
TW202535835A
(zh)
|
2023-11-14 |
2025-09-16 |
美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 |
可電離類脂質組成物及其治療用途
|
|
CA3254064A1
(en)
|
2023-11-15 |
2025-05-21 |
BioNTech SE |
Immunogenic compositions against SARS-CoV-2
|
|
WO2025106754A1
(en)
|
2023-11-15 |
2025-05-22 |
BioNTech SE |
Coronavirus vaccine
|
|
WO2025104695A1
(en)
*
|
2023-11-16 |
2025-05-22 |
Corti Therapeutics Pte. Ltd. |
Ionizable cationic lipids and lipid nanoparticles thereof
|
|
WO2025106930A1
(en)
|
2023-11-17 |
2025-05-22 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides encoding glucagon-like peptide 2 (glp-2) and uses thereof
|
|
WO2025106915A1
(en)
|
2023-11-17 |
2025-05-22 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides encoding glucagon-like peptide 1 (glp-1) and uses thereof
|
|
US20250161347A1
(en)
|
2023-11-22 |
2025-05-22 |
Flagship Pioneering Innovations Vii, Llc |
Methods and compositions for treating non-alcoholic fatty liver disease
|
|
WO2025109173A1
(en)
|
2023-11-22 |
2025-05-30 |
Advantage Therapeutics, Inc. |
Nucleic acid encoding klotho for use in therapeutic and non-therapeutic methods for reducing body weight
|
|
EP4566618A1
(en)
|
2023-12-06 |
2025-06-11 |
ADvantage Therapeutics, Inc. |
Nucleic acid encoding klotho for use in therapeutic and non-therapeutic methods for reducing body weight
|
|
WO2025117877A2
(en)
|
2023-12-01 |
2025-06-05 |
Flagship Pioneering Innovations Vii, Llc |
Cas nucleases and related methods
|
|
US12364773B2
(en)
|
2023-12-01 |
2025-07-22 |
Recode Therapeutics, Inc. |
Lipid nanoparticle compositions and uses thereof
|
|
TW202527910A
(zh)
*
|
2023-12-13 |
2025-07-16 |
大陸商上海瑞宏迪醫藥有限公司 |
一種陽離子脂質及其應用
|
|
WO2025124711A1
(en)
|
2023-12-13 |
2025-06-19 |
BioNTech SE |
Glycolipid compositions
|
|
WO2025128871A2
(en)
|
2023-12-13 |
2025-06-19 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
US20250332281A2
(en)
|
2023-12-15 |
2025-10-30 |
Capstan Therapeutics, Inc. |
Humanized anti-cd8 antibodies and uses thereof
|
|
WO2025129158A1
(en)
|
2023-12-15 |
2025-06-19 |
The Broad Institute, Inc. |
Engineered arc delivery vesicles and uses thereof
|
|
WO2025133115A1
(en)
|
2023-12-21 |
2025-06-26 |
Ose Immunotherapeutics |
Lipid-based nanoparticles comprising il-35
|
|
WO2025137646A1
(en)
|
2023-12-22 |
2025-06-26 |
Recode Therapeutics, Inc. |
Gene editing methods and compositions for treating cystic fibrosis
|
|
WO2025144938A1
(en)
|
2023-12-26 |
2025-07-03 |
Emmune, Inc. |
Systems for nucleic acid transfer
|
|
WO2025141521A1
(en)
|
2023-12-29 |
2025-07-03 |
Sanofi |
Lipids having dendritic moieties
|
|
WO2025149492A1
(en)
|
2024-01-08 |
2025-07-17 |
BioNTech SE |
Rna encoding an immune inhibitory il-1 family member
|
|
WO2025155753A2
(en)
|
2024-01-17 |
2025-07-24 |
Renagade Therapeutics Management Inc. |
Improved gene editing system, guides, and methods
|
|
WO2025157848A1
(en)
|
2024-01-23 |
2025-07-31 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the intravenous treatment of sanfilippo syndrome type iiib
|
|
WO2025160381A1
(en)
|
2024-01-26 |
2025-07-31 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
|
US20250375499A1
(en)
|
2024-01-26 |
2025-12-11 |
Flagship Pioneering Innovations Vii, Llc |
Immunoreceptor inhibitory proteins and related methods
|
|
WO2025166238A1
(en)
|
2024-01-31 |
2025-08-07 |
Orna Therapeutics, Inc. |
Fast-shedding polyethylene glycol lipids
|
|
WO2025174765A1
(en)
|
2024-02-12 |
2025-08-21 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2025186293A1
(en)
|
2024-03-06 |
2025-09-12 |
Institut National de la Santé et de la Recherche Médicale |
Chmp2b mutants for use for treating infection
|
|
WO2025194019A1
(en)
|
2024-03-14 |
2025-09-18 |
Flagship Pioneering Innovations Vii, Llc |
Methods for treating liver fibrosis and non-alcoholic fatty liver disease
|
|
WO2025196065A1
(en)
|
2024-03-20 |
2025-09-25 |
Sanofi |
Novel homocysteine based lipids and their use for delivery of nucleic acids
|
|
WO2025202213A1
(en)
|
2024-03-26 |
2025-10-02 |
Institut National de la Santé et de la Recherche Médicale |
Lipid nanoparticle loaded with antitumoral agent and functionnalized to target immosuppressive cells
|
|
WO2025210521A1
(en)
|
2024-04-04 |
2025-10-09 |
Genevant Sciences Gmbh |
Lipid nanoparticles for stimulating t cells
|
|
WO2025210520A1
(en)
|
2024-04-04 |
2025-10-09 |
Genevant Sciences Gmbh |
Lipid nanoparticles for inducing an immunological response
|
|
WO2025217275A2
(en)
|
2024-04-10 |
2025-10-16 |
Flagship Pioneering Innovations Vii, Llc |
Immune cell targeted compositions and related methods
|
|
CN118388360B
(zh)
|
2024-04-17 |
2025-04-04 |
北京悦康科创医药科技股份有限公司 |
含有苯环结构的长效脾靶向阳离子脂质化合物、包含其的组合物及用途
|
|
US20250353881A1
(en)
|
2024-05-16 |
2025-11-20 |
Flagship Pioneering Innovations Vii, Llc |
Immunoreceptor inhibitory proteins and related methods
|
|
WO2025240946A1
(en)
|
2024-05-17 |
2025-11-20 |
Intellia Therapeutics, Inc. |
Lipid nanoparticles and lipid nanoparticle compositions
|
|
WO2025245188A2
(en)
|
2024-05-21 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Methods of treating liver steatosis and non-alcoholic fatty liver disease
|
|
WO2025245111A1
(en)
|
2024-05-22 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Immunoreceptor targeting proteins and related methods
|
|
WO2025250751A1
(en)
|
2024-05-31 |
2025-12-04 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|